Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4882

Introduced
7/25/23  
Refer
7/25/23  

Caption

Clinical Laboratory Price Transparency Act of 2023

Impact

The proposed legislation aims to improve the availability of pricing information, reflecting a growing trend toward transparency in healthcare costs. By requiring applicable laboratories to update pricing information annually, the bill seeks to provide a standardized approach for patients and insurers to compare costs across different laboratories. This could significantly affect how diagnostic tests are sourced and paid for under the Medicare program, potentially leading to lower costs for beneficiaries and improved access to necessary medical services.

Summary

House Bill 4882, formally titled the Clinical Laboratory Price Transparency Act of 2023, seeks to amend Title XVIII of the Social Security Act by promoting laboratory price transparency under the Medicare program. The bill mandates that starting January 1, 2025, applicable laboratories providing specified clinical diagnostic tests must publicly post the discounted cash prices or gross charges for these tests on a designated internet website. This measure aims to empower patients and healthcare providers with clearer pricing information, ultimately to foster competition and reduce unnecessary healthcare expenditure.

Contention

Notable points of contention within the discussions surrounding HB4882 include concerns about the administrative burden it may impose on laboratories, especially smaller ones that may struggle with compliance to the new transparency requirements. Critics argue that while transparency is essential, the implementation could lead to challenges that may affect healthcare delivery, particularly in rural or underserved areas. Furthermore, the Secretary of Health and Human Services is granted enforcement capabilities and the authority to impose civil monetary penalties for non-compliance, which could raise further apprehension among stakeholders regarding the financial implications of violation.

Companion Bills

US HB4822

Related Health Care Price Transparency Act of 2023

Previously Filed As

US HB4828

Imaging Services Price Transparency Act of 2023

US HB4839

Hospital and ASC Price Transparency Act of 2023

US HB4822

Health Care Price Transparency Act of 2023

US HB3248

Diagnostic Lab Testing Transparency Act

US HB8

Drug Pricing Transparency and Accountability Act

US HB2691

Transparent PRICE Act Transparent Prices Required to Inform Consumer and Employers Act

US HB4905

Health Insurance Price Transparency Act of 2023

US HB1613

Drug Price Transparency in Medicaid Act of 2023

US HB1835

Saving Access to Laboratory Services Act

US SB1131

Drug Price Transparency Act of 2023

Similar Bills

CA AB866

Food and agriculture: Feed Inspection Advisory Board: California Seed Law.

US SB2676

Cloud LAB Act of 2025 Cloud Labs to Advance Biotechnology Act of 2025

LA SR178

Establishes and provides for the Task Force on Funding the Acadiana Criminalistics Laboratory.

VT H0422

An act relating to testing of groundwater samples from contaminated sites at the State Agricultural and Environmental Laboratory

MD HB863

Courts - Expert Witnesses - Letter of Exception

MD SB26

Automatic Expungement - Clarification

US SB5527

A bill to accelerate the development, demonstration, and deployment of new technologies and innovative solutions to address the environmental cleanup mission of the Department of Energy, and for other purposes.

MI SB0148

Animals: research facilities; reporting requirements and penalties for noncompliance; provide for. Amends sec. 12 of 1969 PA 224 (MCL 287.392) & adds secs. 11a & 12a. TIE BAR WITH: SB 0149'23